Patents by Inventor William Fleming Hoggan Jarrett

William Fleming Hoggan Jarrett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6380157
    Abstract: The L2 protein of papillomavirus (particularly BPV-2 and BPV-4) has been cloned as a fusion protein with beta-galactosidase and GST; both as the whole protein and as fragments. Vaccination of calves is found to have both a prophylactic effect in tumour prevention and a therapeutic effect in tumour regression.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: April 30, 2002
    Assignee: Cancer Research Campaign Technology Limited
    Inventors: William Fleming Hoggan Jarrett, Maria Saveria Campo, Kenneth Thomas Smith
  • Patent number: 6020309
    Abstract: The invention provides pharmaceutical formulations for Immunizing against papillomavirus tumors or lesions. Formulations may be selected from the group consisting of: (i) a formulation which comprises a papillomavirus (PV) L2 protein or fragment thereof that is effective to provide a protective effect to lessen the occurrence and severity of lesions or tumors caused by PV infection and an aluminum compound; (ii) a formulation which comprises a bovine papillomavirus (BPV) L2 protein or said fragment thereof and an aluminum compound: (iii) a formulation which comprises a BPV4 L2 protein or said fragment thereof and an aluminum compound; (iv) a formulation which comprises a BPV-4 protein or said fragment thereof and an adjuvant; (v) a formulation which comprises a BPV-4 L2 protein or said fragment thereof and an adjuvant; and (vi) a formulation which comprises a BPV4 protein or said fragment thereof and an aluminum compound.
    Type: Grant
    Filed: January 24, 1996
    Date of Patent: February 1, 2000
    Assignee: Cancer Research Campaign Technology Limited
    Inventors: Maria Saveria Campo, William Fleming Hoggan Jarrett
  • Patent number: 4117112
    Abstract: The present invention encompasses a vaccine for the prevention of disease associated with feline leukemia virus which comprises an effective amount of an adjuvant and about 10.sup.5 -10.sup.7 feline lymphoblastoid cells chronically infected with feline leukemia virus and having viral associated antigen on their surface wherein the virus and cells are inactivated by chemical or physical means without destroying immunogenicity.
    Type: Grant
    Filed: May 19, 1977
    Date of Patent: September 26, 1978
    Assignee: University of Glasgow
    Inventors: William Fleming Hoggan Jarrett, James Oswald Jarrett, Lindsay Joan Mackey
  • Patent number: 4086134
    Abstract: Vaccines affording protection against the diseases resulting from infection of cats with feline leukemia virus are produced from cells infected with that virus or from the virus alone.
    Type: Grant
    Filed: February 22, 1977
    Date of Patent: April 25, 1978
    Assignee: University of Glasgow
    Inventors: William Fleming Hoggan Jarrett, James Oswald Jarrett, Lindsay Joan Mackey
  • Patent number: 4034081
    Abstract: Vaccines affording protection against the diseases resulting from infection of cats with feline leukemia virus are produced from cells infected with that virus or from the virus alone.
    Type: Grant
    Filed: March 18, 1976
    Date of Patent: July 5, 1977
    Assignee: University of Glasgow
    Inventors: William Fleming Hoggan Jarrett, James Oswald Jarrett, Lindsay Joan Mackey
  • Patent number: 3966907
    Abstract: Vaccines affording protection against the diseases resulting from infection of cats with feline leukemia virus are produced from cells infected with that virus or from the virus alone.
    Type: Grant
    Filed: September 13, 1974
    Date of Patent: June 29, 1976
    Assignee: University of Glasgow
    Inventors: William Fleming Hoggan Jarrett, James Oswald Jarrett, Lindsay Joan Mackey